Data from this report is of relevance to (i) the routine identification of lamin B1 in breast cancer tissue using immunohistochemistry (IHC), (ii) the study of TIS induction in breast cancer tissue as a consequence of exposure to cancer chemotherapy, and (iii) determining the contribution of lamin B1 to clinical outcomes of breast cancer treatment. The gene discussed is LMNB1; the disease is breast carcinoma.